Jamieson W R, Burr L H, Miyagishima R T, Fradet G J, Janusz M T, Tyers F O, MacNab J, Chan F
Division of Cardiovascular and Thoracic Surgery, University of British Columbia, Vancouver, Canada.
Ann Thorac Surg. 1995 Aug;60(2 Suppl):S241-7. doi: 10.1016/0003-4975(95)00299-z.
The Carpentier-Edwards standard (CE-S) porcine bioprosthesis was implanted in 1214 operations (1975 to 1985) and the Carpentier-Edwards supraannular (CE-SAV) bioprosthesis was implanted in 2,489 operations (1982 to 1992 inclusive). The early mortality was 7.6% and 7.4% for the CE-S and CE-SAV groups, respectively; the late mortality was 5.3% per patient-year and 4.9% per patient-year, respectively. The cumulative follow-up was 9,968 patient-years for the CE-S group and 12,784 patient-years for the CE-SAV group. Concomitant procedures were performed in 26.8% of the patients who received a CE-S and in 40.9% of those who received a CE-SAV (p < 0.05). The mean age of the patients receiving a CE-S was 57.3 years (range, 8 to 85 years) and was 64.1 years (range, 6 to 89 years) in those receiving a CE-SAV. The CE-S group consisted of 578 atrial valve replacements (AVRs), 512 mitral valve replacements (MVRs), and 115 multiple valve replacements (MRs). The CE-SAV group consisted of 1,335 AVRs, 938 MVRs, and 200 MRs. There was a total of 165 cases of structural valve deterioration (SDV) in the CE-SAV group (AVR, 35; MVR, 98; and MR, 32). The effect of trimming the aortic wall was also considered: 20 of the 931 trimmed prostheses used for MVRs and MRs and none of the 207 reduced-trimmed prostheses exhibited SVD. The cumulative follow-up was 5,422 years for the patients with trimmed prostheses and 470 for those with reduced-trimmed prostheses.(ABSTRACT TRUNCATED AT 250 WORDS)
1975年至1985年期间,1214例手术植入了卡彭蒂埃-爱德华兹标准(CE-S)猪生物瓣膜;1982年至1992年(含)期间,2489例手术植入了卡彭蒂埃-爱德华兹瓣环上(CE-SAV)生物瓣膜。CE-S组和CE-SAV组的早期死亡率分别为7.6%和7.4%;晚期死亡率分别为每年每例患者5.3%和4.9%。CE-S组的累积随访时间为9968患者年,CE-SAV组为12784患者年。接受CE-S的患者中有26.8%进行了同期手术,接受CE-SAV的患者中有40.9%进行了同期手术(p<0.05)。接受CE-S的患者平均年龄为57.3岁(范围8至85岁),接受CE-SAV的患者平均年龄为64.1岁(范围6至89岁)。CE-S组包括578例心房瓣膜置换术(AVR)、512例二尖瓣置换术(MVR)和115例多瓣膜置换术(MR)。CE-SAV组包括1335例AVR、938例MVR和200例MR。CE-SAV组共有165例结构性瓣膜退化(SDV)病例(AVR 35例、MVR 98例、MR 32例)。还考虑了修剪主动脉壁的效果:用于MVR和MR的931个修剪后的假体中有20个,207个减少修剪的假体中无一出现SVD。修剪后假体患者的累积随访时间为5422年,减少修剪后假体患者的累积随访时间为470年。(摘要截断于250字)